iBio, Inc. financial data

Symbol
IBIO on Nasdaq
Location
600 Madison Avenue, Suite 1601, New York, NY
Fiscal year end
June 30
Latest financial report
10-Q/A - Q3 2025 - Nov 17, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 336 % +103%
Quick Ratio 0 %
Debt-to-equity 33.2 % -62.2%
Return On Equity -83.6 % +34%
Return On Assets -62.8 % +6.84%
Operating Margin -53.6K % -2906%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19.7M shares +128%
Common Stock, Shares, Outstanding 20.3M shares +134%
Entity Public Float 22.4M USD +406%
Common Stock, Value, Issued 20K USD +122%
Weighted Average Number of Shares Outstanding, Basic 53M shares +514%
Weighted Average Number of Shares Outstanding, Diluted 53M shares +514%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 50K USD -97.2%
Revenue from Contract with Customer, Excluding Assessed Tax 500K USD
Research and Development Expense 10.6M USD +116%
General and Administrative Expense 10.4M USD -4.92%
Operating Income (Loss) -20.4M USD -30.8%
Nonoperating Income (Expense) 339K USD -73.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -20.1M USD +13.1%
Earnings Per Share, Basic -1 USD/shares +35.2%
Earnings Per Share, Diluted -1 USD/shares +35.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 28.1M USD +155%
Cash, Cash Equivalents, and Short-term Investments 6.43M USD -34.5%
Accounts Receivable, after Allowance for Credit Loss, Current 65K USD
Inventory, Net 0 USD
Assets, Current 50.8M USD +334%
Property, Plant and Equipment, Net 3.21M USD -8.57%
Operating Lease, Right-of-Use Asset 1.96M USD -4.53%
Intangible Assets, Net (Excluding Goodwill) 6.84M USD +27.6%
Assets 64.2M USD +162%
Accounts Payable, Current 2.82M USD +230%
Employee-related Liabilities, Current 876K USD -44.1%
Accrued Liabilities, Current 850K USD -21.1%
Contract with Customer, Liability, Current 1.15M USD +188%
Liabilities, Current 6.05M USD +74.3%
Operating Lease, Liability, Noncurrent 2.07M USD -5.96%
Liabilities 8.12M USD +20%
Accumulated Other Comprehensive Income (Loss), Net of Tax -15K USD
Retained Earnings (Accumulated Deficit) -338M USD -6.33%
Stockholders' Equity Attributable to Parent 56M USD +216%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 56M USD +216%
Liabilities and Equity 64.2M USD +162%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.67M USD -52.5%
Net Cash Provided by (Used in) Financing Activities 46.7M USD
Net Cash Provided by (Used in) Investing Activities -21.5M USD -3114%
Common Stock, Shares Authorized 275M shares 0%
Common Stock, Shares, Issued 20.3M shares +134%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 19.5M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 28.3M USD +152%
Interest Paid, Excluding Capitalized Interest, Operating Activities 36K USD -36.8%
Deferred Tax Assets, Valuation Allowance 63.4M USD +15.6%
Depreciation 123K USD +2.5%
Payments to Acquire Property, Plant, and Equipment 32K USD
Lessee, Operating Lease, Liability, to be Paid 3.01M USD -17.9%
Property, Plant and Equipment, Gross 4.83M USD +3.98%
Operating Lease, Liability, Current 504K USD +2.86%
Lessee, Operating Lease, Liability, to be Paid, Year Two 693K USD +2.82%
Lessee, Operating Lease, Liability, to be Paid, Year One 674K USD +3.22%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 715K USD +3.18%
Deferred Tax Assets, Operating Loss Carryforwards 56.1M USD +14.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 735K USD +2.8%
Operating Lease, Payments 141K USD 0%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 20K USD 0%
Share-based Payment Arrangement, Expense 1.44M USD -11.7%
Interest Expense 52K USD +48.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%